Solid Cancers After Bone Marrow Transplantation
- 15 January 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (2), 464-471
- https://doi.org/10.1200/jco.2001.19.2.464
Abstract
PURPOSE: To evaluate the incidence and associated risk factors of solid cancers after bone marrow transplantation (BMT). PATIENTS AND METHODS: We analyzed 2,129 patients who had undergone BMT for hematologic malignancies at the City of Hope National Medical Center between 1976 and 1998. A retrospective cohort and nested case-control study design were used to evaluate the role of pretransplantation therapeutic exposures and transplant conditioning regimens. RESULTS: Twenty-nine patients developed solid cancers after BMT, which represents a two-fold increase in risk compared with a comparable normal population. The estimated cumulative probability (± SE) for development of a solid cancer was 6.1% ± 1.6% at 10 years. The risk was significantly elevated for liver cancer (standardized incidence ratio [SIR], 27.7; 95% confidence interval [CI], 1.9 to 57.3), cancer of the oral cavity (SIR, 17.4; 95% CI, 6.3 to 34.1), and cervical cancer (SIR, 13.3; 95% CI, 3.5 to 29.6). Each of the two patients with liver cancer had a history of chronic hepatitis C infection. All six patients with squamous cell carcinoma of the skin had chronic graft-versus-host disease. The risk was significantly higher for survivors who were younger than 34 years of age at time of BMT (SIR, 5.3; 95% CI, 2.7 to 8.6). Cancers of the thyroid gland, liver, and oral cavity occurred primarily among patients who received total-body irradiation. CONCLUSION: The risk of radiation-associated solid tumor development after BMT is likely to increase with longer follow-up. This underscores the importance of close monitoring of patients who undergo BMT.Keywords
This publication has 20 references indexed in Scilit:
- Solid Cancers after Bone Marrow TransplantationThe New England Journal of Medicine, 1997
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseThe New England Journal of Medicine, 1996
- Incidence of Second Cancers in Patients Treated for Hodgkin's DiseaseJNCI Journal of the National Cancer Institute, 1995
- Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non- Hodgkin's lymphomaBlood, 1994
- Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress [editorial]Blood, 1994
- Second Cancers Among Long-term Survivors of Non-Hodgkin's LymphomaJNCI Journal of the National Cancer Institute, 1993
- Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter; comment]Blood, 1992
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaThe New England Journal of Medicine, 1989
- Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantationBlood, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958